2023
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US
Kc M, Fan J, Hyslop T, Hassan S, Cecchini M, Wang S, Silber A, Leapman M, Leeds I, Wheeler S, Spees L, Gross C, Lustberg M, Greenup R, Justice A, Oeffinger K, Dinan M. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Network Open 2023, 6: e2323115. PMID: 37436746, PMCID: PMC10339147, DOI: 10.1001/jamanetworkopen.2023.23115.Peer-Reviewed Original ResearchConceptsLong-term survivorsCancer-specific mortalityColorectal cancerCancer cohortReceptor statusInitial diagnosisGleason scoreProstate cancerBreast cancerLong-term adult survivorsMedian cancer-specific survivalEnd Results cancer registryProstate-specific antigen levelRectal cancer cohortCancer-specific survivalStage III diseaseYear of diagnosisProgesterone receptor statusEstrogen receptor statusProportion of deathsSurvival time ratioEarly-stage cancerNononcologic outcomesIndex cancerLocalized disease
2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.
Spees L, Wheeler S, Jackson B, Baggett C, Wilson L, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2021, 39: 87-87. DOI: 10.1200/jco.2020.39.28_suppl.87.Peer-Reviewed Original ResearchMetastatic renal cell carcinomaPatient-level factorsProvider-level factorsRenal cell carcinomaIndex dateRace/ethnicityInitial diagnosisCell carcinomaRisk ratioState cancer registry dataNumber of comorbiditiesMore comorbid conditionsPatient-level predictorsCancer registry dataProportion of daysProvider-level variablesPrescription drug filesMedian PDCMRCC diagnosisMRCC patientsPatient characteristicsPharmacy claimsComorbid conditionsMetastatic diagnosisMedical oncology
2015
Otolaryngology utilization of speech‐language pathology services for voice disorders
Cohen SM, Dinan MA, Kim J, Roy N. Otolaryngology utilization of speech‐language pathology services for voice disorders. The Laryngoscope 2015, 126: 906-912. PMID: 26308555, DOI: 10.1002/lary.25574.Peer-Reviewed Original ResearchConceptsLaryngeal/voice disordersSpeech-language pathology servicesSLP evaluationLaryngeal diagnosisDiagnosis changeSLP servicesVoice disordersMultivariable logistic regression analysisPathology servicesClinical Modification codesLogistic regression analysisVoice therapy sessionsPatient ageHealthcare utilizationInitial diagnosisPatient factorsNinth RevisionUnique patientsStudy criteriaVoice-disordered patientsRetrospective analysisStudy populationInternational ClassificationGreater oddsPatients
2013
Diagnosis Change in Voice‐Disordered Patients Evaluated by Primary Care and/or Otolaryngology: A Longitudinal Study
Cohen SM, Dinan MA, Roy N, Kim J, Courey M. Diagnosis Change in Voice‐Disordered Patients Evaluated by Primary Care and/or Otolaryngology: A Longitudinal Study. Otolaryngology 2013, 150: 95-102. PMID: 24264568, DOI: 10.1177/0194599813512982.Peer-Reviewed Original ResearchConceptsPrimary care physiciansOtolaryngology groupLaryngeal diagnosisInitial diagnosisClinical Modification codesHealth care utilizationVoice disordersLaryngeal cancer diagnosisNonspecific dysphoniaOutpatient visitsAcute laryngitisCare physiciansCare utilizationNinth RevisionPrimary careDifferential diagnosisRetrospective analysisAppropriate treatmentInclusion criteriaDiagnosis changeInternational ClassificationPatientsAccurate diagnosisLaryngeal disordersStudy design